May 2022 Written by: Edward Wood, MD Austin Retina Associates Austin, TX Wykoff, C. C., F. Abreu, A. P. Adamis, and K. Basu. 2022. “Efficacy, Durability, and Safety of Intravitreal Faricimab with Extended Dosing up to Every 16 Weeks in Patients with Diabetic Macular Oedema (YOSEMITE and RHINE): two randomized, double-masked, phase 3 trials. The Lancet. […]
May 2022 Written by: Daniel Su, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Hwang ES, Kraker JA, Griffin KJ, Sebag J, Weinberg DV, Kim JE. Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment. Ophthalmol Retina. 2020 Feb;4(2):148-153. Posterior vitreous detachment (PVD) is the age-related separation of vitreous from […]
April 2022 Written by: Mohsin H. Ali, MD Retina Group of Washington Washington D.C. Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Efficacy, durability, […]
April 2022 Written by: Akshay Thomas, M.D. Tennessee Retina Nashville, TN Khanani AM, Zarbin MA, Barakat MR, et al. Safety outcomes of brolucizumab in neovascular age-related macular degeneration: results from the iris registry and komodo healthcare map. JAMA Ophthalmol. 2022;140(1):20-28. Treatment options for wet AMD include off-label use of bevacizumab or use of an FDA-approved […]
April 2022 Written by: Vlad Matei, M.D. Rocky Mountain Retina Associates Boulder, CO Marlow E, Hassan T, Faia L, et al. Vitrectomy for symptomatic asteroid hyalosis. J Vitreoretin Dis 2021;5(5):420-424. Asteroid hyalosis (AH) is a common and benign degeneration consisting of calcium- and lipid-rich opacities, termed asteroid bodies (ABs), accumulating in the vitreous gel. Until […]
March 2022 Written by: Katherine E. Talcott, MD Cole Eye Institute Cleveland Clinic Azad AD, Chandramohan A, Li AS, Rosenblatt TR, Reeves M-GR, Pasricha MV, Ludwig CA, Nguyen A, Winges KM, Wang SY, Pan CK, Moss HE, Do DV, Fountain TR, Kossler AL, Representation of Women in Ophthalmology Subspecialty Societies over 20 Years, Ophthalmology (2022), […]
March 2022 Written by: Maxwell Stem, MD Pennsylvania Retina Specialists, PC Gretchenig C, Reiter GS, Riedl S, Arnold J, Guymer R, Gerendas BS, Bogunovic H, Schmidt-Erfurth U. Impact of Residual Subretinal Fluid Volumes on Treatment Outcomes in a Subretinal Fluid-Tolerant Treat-and-Extend Regimen. Retina. 2021;41(11):2221-2228. The axiom that the goal of anti-VEGF therapy is to completely […]
February 2022 Written by: Nika Bagheri, MD California Retina Consultants and Research Foundation Santa Barbara, CA Holekamp NM, Campochiaro PA, Chang M, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C, on behalf of all Archway Investigators. ARCHWAY: Randomized […]
